Caged Phosphoproteins by Rothman, Deborah M. et al.
1Supporting Information for:
Caged Phosphoproteins
Deborah M. Rothman1, E. James Petersson2, M. Eugenio Vazquez1, Gabriel S. Brandt2,  Dennis
A. Dougherty2*, and Barbara Imperiali1,3*
1Departments of Chemistry and 3Biology, Massachusetts Institute of Technology, Cambridge,
MA 02139, 2Division of Chemistry and Chemical Engineering, California Institute of
Technology, Pasadena, CA 91125
e-mail: dadoc@caltech.edu,  imper@mit.edu
RECEIVED DATE (to be automatically inserted after your manuscript is accepted if
required according to the journal that you are submitting your paper to)
2Table of Contents
Topic Page
General Procedures 3
Chemical Synthesis 4
Biochemical Synthesis and Molecular Biology 8
NMR data 12
References 27
3General Experimental Procedures
All starting amino acids and reagents used are commercially available, unless referenced to synthetic procedure.
Dichloromethane was distilled from calcium hydride under nitrogen, and tetrahydrofuran was distilled from sodium
under argon. Analytical thin-layer chromatography (TLC) was carried out on F254 250-µm silica gel plates, and
visualized by UV lamp.  1H NMR spectra were acquired on a Bruker Avance (DPX) 400 MHz spectrometer or
Varian Mercury 300 MHz spectrometer.  31P NMR spectra were acquired on a Varian Mercury 300 MHz
spectrometer. 13C NMR spectra were acquired on a Varian Inova 500 MHz spectrometer or a Bruker Avance (DPX)
400 MHz spectrometer.  Chemical shifts are reported in ppm from a standard (tetramethylsilane for 1H, H2PO4 for
31P, CDCl3 for 13C), and J values are in Hertz.  High-resolution mass spectrometry was performed on a Fourier
Transform Mass Spectrometer using an Electrospray Ion Source. High-performance liquid chromatography (HPLC)
was performed using a Waters 600E HPLC fitted with a Waters 600 automated control module and a Waters 2487
dual wavelength absorbance detector recording at 228 and 280 nm. For analytical HPLC a Beckman Ultrasphere
C18, 5 µm, 4.6 x 150 mm reverse-phase column was used. For preparative separations a YMC-pack, C18, 250 x 20
mm reversed phase column was used.  The standard gradient for analytical and preparatory HPLC used was 93:7 to
0:100 over 35 minutes (water:acetonitrile, 0.1% TFA).  Electrospray Ionization Mass Spectrometry (ESI-MS) was
performed on a PerSeptive Biosystems Mariner Biospectrometry Workstation (Turbo Ion Source).  All tRNAs
were analyzed on a PerSeptive Biosystems (Framingham, MA) Voyager DE PRO MALDI-TOF mass spectrometer
operating in linear and positive ion modes with settings as previously described.1
4Chemical Synthesis
O-1-(2-nitrophenyl)ethyl-O’-tertbutyl-N,N-diethyl phosphoramidite (3). To an oven dried flask with stir bar,
hexaethyl phosphorus triamide (1.37 mL, 5.00 mmole) and 4,5-dicyanoimidazole (0.58 g, 4.90 mmole) are dissolved
in anhydrous tetrahydrofuran (THF, 15 mL) under inert atmosphere.  In an oven dried pear flask, tert-Butyl alcohol
(0.48 mL, 5.00 mmole) was dissolved in anhydrous THF (5.0 mL).  In a separate oven dried pear flask, 1-2-
(nitrophenyl)ethyl alcohol (1.00 g, 6.00 mmole) was dissolved in anhydrous THF (1 mL).  The tBuOH solution was
delivered to the phosphoramidite mixture via cannula, and the reaction allowed to stir at room temperature for 15
minutes, at which point, the nitrophenylethyl alcohol mixture was delivered to the reaction flask via cannula.  The
mixture was allowed to stir overnight, in the dark, at room temperature.  The mixture was then concentrated under
reduced pressure, and re-dissolved in ethyl acetate (EtOAc, 150 mL).  The organic solution was washed with 20 %
sodium bicarbonate (NaHCO3, 2 x 150 mL) and brine (1 x 150 mL), then dried over magnesium sulfate (MgSO4),
filtered, and concentrated.  The final product was purified by silica gel flash chromatography (98:2
Hexanes/triethylamine (NEt3), Rf: 0.73,) to give 5 (1.27 g) in 74.0 % yield. 1H NMR (300 MHz, CDCl3) δ ppm: 7.92
(td, JHH = 1.8 Hz, JHH =  8.4 Hz, 2H), 7.65 (tt, JHH = 1.5 Hz, JHH = 7.5, 1H), 7.40, (tt, JHH = 1.5 Hz, JHH = 8.4 Hz, 1 H),
5.55 (m, 1 H), 3.06 (m, 4H), 1.57 (dd, JHH = 4.5 Hz, JHH = 6.3 Hz, 3H), 1.30 (d, JHH = 19.5 Hz, 9H), 1.08 (dt, JHH =
6.0 Hz, JHH =43.5 Hz, 6 H).  31P NMR (121.5 MHz, CDCl3) δ ppm: 139.93, 139.16 (racemic mixture).  13C NMR
(125.8 MHz, CDCl3) 147.9, 142.0, 133.8, 129.6, 128.2, 124.5, 75.5, 67.0, 38.3, 31.3, 25.9, 15.6.  Product is not
stable to MS measurements.
Nα-4-pentenoyl-O-tert-butyl-L-Serine: H-O-tert-butyl-L-Serine (1 a , 500 mg, 3.10 mmole) and N , N -
diisopropylethylamine (DIPEA, 633 µL, 3.70 mmole) were dissolved in THF (30 mL) and water (30 mL).  4-
pentenoic anhydride (676 µL, 3.70 mmole) was dissolved in THF (2 mL), and added to the serine solution.  The
reaction was monitored by TLC (1:1:0.01 hexanes/EtOAc/acetic acid (AcOH), Rf = 0.30), stained with iodine and
ninhydrin.  After the disappearance of starting material, the THF was removed under reduced pressure, and the
water layer extracted with EtOAc (3 x 100 mL).  The organic portions were dried over MgSO4, filtered and
concentrated under reduced pressure.  The product was purified by silica gel flash chromatography (827 mg) in 93.7
% yield.  1H NMR (300 MHz, CDCl3) δ ppm:  6.99 (d, JHH = 8.1 Hz, 1 H), 5.70 (m, 1 H), 4.94 (q, JHH = 17.1, 10.2,
10.2 Hz, 2 H), 4.64 (m, 1 H), 3.71 (dd, JHH = 9 Hz, JHH = 3 Hz, 1 H), 3.46 (dd, JHH = 9.3 Hz, JHH =3 Hz, 1 H), 2.25 (s,
4 H), 0.99 (s, 9 H). 13C NMR (125.8 MHz, CDCl3) δ ppm: 176.0, 173.9, 136.7, 115.8, 73.7, 61.9, 53.0, 35.3, 29.7,
27.3.  ESI-MS: [M-H]- 242.1401 (obsd), 242.1398 (calcd).
Nα-4-pentenoyl-O-tert-butyl-L-Serine cyanomethyl ester: N α-4-pentenoyl-O-tert-butyl-L-Serine (825 mg, 3.39
mmole) was dissolved in chloroacetonitrile (644 µL, 10.20 mmole), and cooled to 0°C, stirring, under argon.
Diazabicyclo[5.4.0]undec-7-ene (DBU, 507 µL, 3.39 mmole) was slowly added to the stirring mixture. The reaction
was allowed to warm to room temperature, and stir overnight under argon.  The reaction mixture was diluted with
EtOAc (150 mL), washed with water (2 x 150 mL), then brine (1 x 150 mL), dried over MgSO4, filtered and
concentrated (1:1 hexanes/EtOAc, Rf = 0.41) (765 mg, 79.9 %).  1H NMR (300 MHz, CDCl3) δ ppm:  6.81 (d, JHH =
8.7 Hz, 1 H), 5.83 (m, 1 H), 5.11 (q, JHH = 18.3, 6.6, 9.9 Hz, 2 H), 4.84 (m, 3 H), 3.86 (dd, JHH = 9.3 Hz, JHH = 3.3
Hz, 1 H), 3.58 (dd, JHH = 9.3 Hz, JHH = 3.3, 1 H), 2.38 (s, 4 H), 1.16 (s, 9 H). 13C NMR (125.8 MHz, CDCl3) δ ppm:
172.7, 169.6, 137.1, 115.7, 114.5, 73.8, 61.9, 52.7, 49.2, 35.2, 29.5, 27.3.  ESI-MS: [MNa]+ 305.1478 (obsd),
305.1472 (calcd).
Nα-4-pentenoyl-L-Serine cyanomethyl ester (2a): Nα-4-pentenoyl-O-tert-butyl-L-Serine cyanomethyl ester (750
mg, 2.69 mmole) was dissolved in an ice-cold solution of triflouroacetic acid (TFA) with 1 % (v/v)
triisopropylsilane (TIS).  The reaction was stirred at 0°C for 4 hours, and determined complete by TLC (EtOAc, Rf =
0.43).  The reaction mixture was poured into ice-cold saturated NaHCO3 (250 mL) and EtOAc (120 mL).  The
organic layer was washed with saturated NaHCO3 (3 x 100 mL), then brine (1 x 100 mL), dried over MgSO4,
filtered, and concentrated under reduced pressure.  The mixture was purified by silica gel flash chromatography to
give the product (156 mg) in 25.6 % yield. 1H NMR (300 MHz, CDCl3) δ ppm:  6.90 (d, JHH = 7.8 Hz, 1 H), 5.87 (m,
1 H), 5.10 (t, JHH = 19.5, 10.8 Hz, 2 H), 4.80 (d, JHH = 1.5 Hz, 3 H), 4.70 (m, 1 H), 4.06 (dd, JHH = 11.7 Hz, JHH = 3.6,
3.3 Hz, 1 H), 3.87 (dd, JHH = 11.4 Hz, JHH = 3.6, 3.6 Hz, 1 H), 2.38 (d, JHH = 3.0 Hz, 4 H).  13C NMR (125.8 MHz,
CDCl3) δ ppm:  173.5, 169.8, 137.0, 116.4, 114.5, 63.0, 54.6, 49.7, 35.8, 29.8.  ESI-MS: [MNa]+ 249.0847 (obsd),
249.0846 (calcd).
5Nα-4-pentenoyl-phospho(1-nitrophenylethyl-2-tert-butyl)-L-Serine cyanomethyl ester (4a): Nα-4-pentenoyl-L-
Serine cyanomethyl ester (2a, 150 mg, 663 µmole) was dissolved in anhydrous THF (2.0 mL), in a round bottom
flask fitted with an oven dried stir bar under argon.  In a separate pear flask, O-1-(2-nitrophenyl)ethyl-O’-tertbutyl-
N,N-diethyl phosphoramidite (3, 340 mg, 995 µmole) and 4,5-dicyanoimidazole (157 mg, 1.33 mmole) were
dissolved in anhydrous THF (1.3 mL), and kept dark.  The phosphoramidite solution was delivered to the serine
solution via syringe, and the reaction was allowed to stir overnight, under argon, in the dark.  The reaction was
judged complete by loss of starting material by TLC.  The mixture was concentrated under reduced pressure, and
redissolved in EtOAc (50 mL).  The organic layer was washed with 10 % NaHCO3 (2 x 80 mL), brine (1 x 80 mL),
then dried over sodium sulfate (Na2SO4), decantend and concentrated.  The phosphite mixture was then oxidized
with tert-butyl hydroperoxide (tBuOOH, 266 µL of 5 M solution in decane, 1.33 mmole) in dichloromethane
(CH2Cl2, 10 mL) for one hour, in the dark.  The mixture was diluted with CH2Cl2 (50 mL), and washed with 10 %
NaHCO3 (2 x 80 mL) and brine (1 x 80 mL), then dried over MgSO4, filtered and concentrated.  The product was
partially purified by silica gel flash chromatography (1:2 hex/EtOAc, Rf = 0.26), and carried on to the next step
before final purification (68.2 %).
Nα-4-pentenoyl-phospho(1-nitrophenylethyl)-L-Serine cyanomethyl ester (5a): Nα-4-pentenoyl-phospho(1-
nitrophenylethyl-2-tert-butyl)-L-Serine cyanomethyl ester (4a, 69 mg, 135 µmole) was dissolved in acetonitrile
(MeCN, 4.0 mL) at room temperature, stirring, and kept dark.  A solution of TFA (1.0 mL) with TIS (50 µL) was
added to the solution, and stirred for 10 minutes at room temperature.  The mixture was then poured into ice-cold
saturated NaHCO3 (4.0 mL).  The product mixture was purified by reversed phase HPLC. (93:7 to 0:100
water/MeCN/0.1 % TFA, over 35 minutes, Rt = 22.68 min) in 99 % yield (61.0 mg). 1H NMR (300 MHz, CDCl3) δ
ppm: 8.00 (ddd, JHH = 8.1 Hz, JHH = 3.6, 3.6 Hz, JHH = 1.5, 1.2, 1.2, 1.5 Hz, 1 H), 7.79 (m, 2 H), 7.53 (m, 1 H), 6.04
(m, 1 H), 5.86 (m, 1 H), 5.11 (m, 2 H), 4.88 (m, 3 H), 4.40 (m, 3 H), 2.40 (d, JHH = 7.5 Hz, 4 H), 1.71 (dd, JHH = 6.3
Hz, JHH = 1.2, 1.2 Hz, 3 H).  13C NMR (125.8 MHz, CDCl3) δ ppm:  173.7, 168.3, 147.3, 137.5, 137.0, 134.6, 129.5,
128.2, 125.0, 116.3, 114.2, 73.3, 67.2, 52.8, 50.1, 35.5, 29.7, 24.7.  31P (121.5 MHz, CDCl3): -1.382.  ESI-MS: [M-
H]- 454.1017 (obsd), 454.1021 (calcd).
Nα-4-pentenoyl-O-tert-butyl-L-Threonine:  H-O-tert-butyl-L-Threonine (1b, 500 mg, 2.85 mmole) and DIPEA
(683 µL, 3.99 mmole) were dissolved in THF (40 mL) and water (10 mL).  4-pentenoic anhydride (730 µL, 3.99
mmole) was dissolved in THF (5 mL), and added to the threonine solution.  The reaction was monitored by TLC
(1:1:0.01 hexanes/EtOAc/AcOH, Rf = 0.31), stained with iodine and ninhydrin.  After the disappearance of starting
material, the mixture was concentrated under reduced pressure, and the product was purified by silica gel flash
chromatography (625 mg, 85.3 %).  1H NMR (300 MHz, CDCl3) δ ppm:  6.74 (d, JHH = 8.4 Hz, 1 H),  5.88 (m, 1 H),
5.12 (q, JHH = 17.4, 8.1, 10.2 Hz, 2 H), 4.60 (dd, JHH = 8.7 Hz, JHH = 2.7, 2.4 Hz, 1 H), 4.32 (m, 1 H), 2.43 (m, 4 H),
1.20 (s, 9 H), 1.71 (d, JHH = 6.6 Hz, 3 H). 13C NMR (125.8 MHz, CDCl3) δ ppm: 174.3, 174.0, 136.9, 116.0, 75.2,
67.2, 57.7, 35.6, 29.7, 28.4, 20.1.  ESI-MS: [M-H]- 256.1551 (obsd), 256.1554 (calcd).
Nα-4-pentenoyl-O-tert-butyl-L-Threonine cyanomethyl ester: Nα-4-pentenoyl-O-tert-butyl-L-Threonine (390 mg,
1.51 mmole) was dissolved in chloroacetonitrile (478 µL, 7.55 mmole) and cooled to 0°C, stirring, under argon.
DBU (226 µL, 1.51 mmole) was slowly added to the stirring mixture.  The reaction was allowed to warm to room
temperature, and stir overnight under argon.  The reaction mixture was diluted with EtOAc (100 mL), washed with
water (2 x 100 mL) and brine (1 x 100 mL), then dried over MgSO4, filtered and concentrated (1:1 hexanes/EtOAc,
Rf = 0.43) (321 mg, 71.7 %).  1H NMR (300 MHz, CDCl3) δ ppm:  6.39 (d, JHH = 9.0 Hz, 1 H), 5.91 (m, 1 H), 5.14
(q, JHH = 17.1, 7.5, 10.2 Hz, 2 H), 4.78 (d, JHH = 3.0 Hz, 2 H), 4.61 (dd, JHH = 9.3 Hz, JHH = 2.1, 1.8 Hz, 1 H), 4.27
(m, 1 H), 2.42 (d, JHH = 2.7 Hz, 4 H), 1.21 (d, JHH = 6.3 Hz, 3 H), 1.14 (s, 9H).  13C NMR (125.8 MHz, CDCl3) δ
ppm:  173.1, 169.9, 137.1, 115.9, 114.3, 74.5, 67.2, 57.7, 49.1, 35.5, 29.5, 28.6, 21.0. ESI-MS: [MNa]+ 319.1617
(obsd), 319.1628 (calcd).
Nα-4-pentenoyl-L-Threonine cyanomethyl ester (2b): Nα-4-pentenoyl-O-tert-butyl-L-Threonine cyanomethyl
ester (315 mg, 1.06 mmole) was dissolved in an ice-cold solution of TFA with 1 % (v/v) TIS.  The reaction was
stirred at 0°C for two hours, and determined complete by TLC (1:1 hex/EtOAc, Rf = 0.15).  The reaction mixture
was poured into ice-cold saturated NaHCO3 (80 mL) and EtOAc (80 mL).  The organic layer was washed with
saturated NaHCO3 (2 x 80 mL) and brine (1 x 80 mL), then dried over MgSO4, filtered, and concentrated under
reduced pressure.  The mixture was purified by silica gel flash chromatography to give the product (150 mg) in 59.0
% yield. 1H NMR (300 MHz, CDCl3) δ ppm: 6.39 (d, JHH = 8.4 Hz, 1 H), 5.90 (m, 1 H), 5.14 (t, JHH = 17.4, 13.8 Hz,
62 H), 4.87 (q, JHH = 15.6, 7.5, 15.6 Hz, 2 H), 4.69 (dd, JHH = 9.0 Hz, JHH = 2.7, 2.4 Hz, 1 H), 4.46 (qd, JHH = 6.3, 6.3,
6.3 Hz, JHH = 2.4, 2.4, 2.4, 2.4 Hz, 1 H), 2.43 (d, JHH = 2.7 Hz, 4 H), 1.27 (t, JHH = 4.2, 2.1 Hz, 3 H).  13C NMR
(125.8 MHz, CDCl3) δ ppm:  173.7, 170.2, 137.1, 116.4, 114.5, 68.0, 57.5, 49.6, 36.0, 29.8, 20.6.  ESI-MS: [MNa]+
263.1005 (obsd), 263.1002 (calcd).
Nα-4-pentenoyl-phospho(1-nitrophenylethyl-2-tert-butyl)-L-Threonine cyanomethyl ester (4b): Nα-4-
pentenoyl-L-Threonine cyanomethyl ester (140 mg, 582 µmole) was dissolved in anhydrous THF (2 mL), in a round
bottom flask fitted with an oven dried stir bar under argon.  In a separate pear flask, O-1-(2-nitrophenyl)ethyl-O’-
tertbutyl-N,N-diethyl phosphoramidite (3, 299 mg, 874 µmole) and 4,5-dicyanoimidazole (137 mg, 1.16 mmole)
were dissolved in anhydrous THF (1 mL), and kept dark.  The phosphoramidite solution was delivered to the
threonine solution via syringe, and the reaction was allowed to stir overnight, under argon, in the dark.  The reaction
was judged complete by loss of starting material by TLC.  The mixture was concentrated under reduced pressure,
and re-dissolved in EtOAc (80 mL).  The organic layer was washed with 10 % NaHCO3 (2 x 80 mL), brine (1 x 80
mL), then dried over Na2SO4, decantend and concentrated.  The phosphite mixture was then oxidized with tBuOOH
(232 µL of 5 M solution in decane, 1.16 mmole) in dichloromethane (CH2Cl2, 10 mL) for one hour, in the dark.  The
mixture was diluted with CH2Cl2 (70 mL), and washed with 10 % NaHCO3 (2 x 80 mL), brine (1 x 80 mL), then
dried over MgSO4, filtered and concentrated The product was partially purified by silica gel flash chromatography
(Rf = 0.19, 1:1 hex/EtOAc) and carried on to the next step before final purification (70.1 %).
Nα-4-pentenoyl-phospho(1-nitrophenylethyl)-L-Threonine cyanomethyl ester (5b): Nα-4-pentenoyl-phospho(1-
nitrophenylethyl-2-tert-butyl)-L-Threonine cyanomethyl ester (250 mg, 476 µmole) was dissolved in MeCN (3.5
mL) at room temperature, stirring, and kept dark.  A solution of TFA (3.5 mL) with TIS (70 µL) was added to the
solution, and stirred for 15 minutes at room temperature.  The mixture was then poured into ice-cold saturated
NaHCO3 (10 mL).  The mixture was purified by reversed phase HPLC (93:7 to 0:100 water/acetonitrile/0.1 % TFA
over 35 minutes, Rt = 23.86 min) in 41.0 % yield (92.0 mg). 1H NMR (300 MHz, CDCl3) δ ppm:  8.00 (d, JHH =
7,=.8 Hz, 1 H), 7.79 (m, 2 H), 7.55 (m, 1 H), 6.89 (t, JHH = 7.2, 9.0 Hz, 1 H), 6.53 (bs, 1 H),  6.05 (m, 1 H), 5.87 (m,
1 H), 5.13 (m, 2 H), 4.92 (m, 6 H), 2.42 (d, JHH = 2.1 Hz, 4 H), 1.74 (d, JHH = 6.3 Hz, 3 H), 1.35 (dd, JHH = 24.0 Hz,
JHH = 6.3, 6.6 Hz, 3 H).  13C NMR (125.8 MHz, CDCl3) δ  ppm:  174.8, 169.1, 147.8, 137.6, 137.0, 134.7, 129.8,
128.5, 125.2, 116.8, 114.5, 75.8, 73.7, 56.6, 50.5, 35.9, 30.1, 24.9, 19.2.  31P (121.5 MHz, CDCl3): -1.13, -1.17.  ESI-
MS: [M-H]- 468.1168 (obsd), 468.1177 (calcd).
Nα-4-pentenoyl-L-Tyrosine tert-butyl ester: H-L-Tyrosine-tert-butyl ester (475 mg, 2.0 mmol) was dissolved in
anhydrous THF (15 mL) and anhydrous CH2Cl2 (5 mL).  DIPEA (975 µL, 6.0 mmol) was added, and pentenoic
anhydride (440 µL, 2.4 mmol) was added dropwise to the resulting mixture. The reaction mixture was stirred at
room temperature for 45 minutes and then concentrated under reduced pressure. The clear oil was purified by silica
gel flash chromatography ( Rf = 0.70, 2:3 hex/EtOAc) to give the desired product as a clear oil (568 mg, 89%). 1H-
NMR (400 MHz, CDCl3, δ): 1.42 (s, 9H), 2.0-2.3 (m, 4H), 2.9-3.0 (m, 2H), 4.71 (dd, 1H, J1 = 7.6 Hz, JHH = 6.2 Hz),
4.94-5.01 (m, 2H), 5.67-5.77 (m, 1H), 6.42 (d, 1H, JHH = 7.9 Hz), 6.77 (d, 2H, JHH = 8.3 Hz), 6.97 (d, 2H, JHH = 8.3
Hz), 8.28 (s, 1H). 13C-NMR (100.6 MHz, CDCl3, δ): 172.9, 171.8, 155.8, 136.5, 130.4, 126.8, 115.9, 115.5, 82.6,
53.9, 37.2, 35.6, 29.4, 27.8. ESI-MS: [M+H]+ 320.1855 (obsd), 320.1862 (calcd).
Nα-4-pentenoyl-phospho(1-nitrophenylethyl-2-cyanoethyl)-L-Tyrosine tert-butyl ester: Nα-4-pentenoyl-L-
Tyrosine tert-butyl ester (1.13 g, 3.55 mmol) was placed in an oven dried round bottom flask with molecular sieves
and dissolved in anhydrous THF (10 mL). In a separate flask, N,N-Diisopropyl-1-nitrophenylethyl-2-cyanoethyl
phosphoramidite2 (1.95 g, 5.32 mmol) was dissolved in anhydrous THF (12 mL) and activated with 1H-tetrazole
(373 mg, 5.32 mmol) for 10 minutes.  The resulting mixture was then added dropwise to the tyrosine solution. The
reaction was stirred overnight at room temperature in the dark.  The mixture was filtered over celite and
concentrated under reduced pressure, then re-dissolved in CH2Cl2 (75 mL), washed with 1% aqueous NaHCO3 (2 x
40 mL), dried over Na2SO4, decanted and concentrated. The phosphite resdiue was then dissolved in anhydrous
CH2Cl2 (20 mL) and tBuOOH (800 µL, 6M solution in decane) was added dropwise.  After 35 minutes, the reaction
mixture was diluted with 30 mL CH2Cl2, washed with 1% aqueous NaHCO3 (2 x 30 mL), then dried with Na2SO4,
decanted and concentrated.  The resulting pale yellow oil was purified by silica gel flash chromatography (Rf = 0.50,
2:3 hex/EtOAc) to give the product as a clear oil (1.64 g, 77.0 %). 1H-NMR (400 MHz, CDCl3, δ): 1.32 (s, 9H), 1.64
(dd, 3H, JHH = 6.3 Hz, JHH = 13.6 Hz), 2.16-2.26 (m, 4H), 2.54-2.59 (m, 2H), 2.90-3.00 (m, 2H), 4.11-4.20 (m, 2H),
4.51-4.66 (m, 1H), 4.86-4.95 (m, 2H), 5.20-5.40 (m, 1H), 6.2-6.3 (m, 1H), 6.5-6.65 (m, 1H), 6.90-7.07 (m, 4H),
77.36-7.45 (m, 1H), 7.55-7.73 (m, 2H), 7.89 (d, 1H, JHH = 8.2 Hz). 13C-NMR (100.6 MHz, CDCl3, δ): 171.9, 170.5,
148.8, 146.6, 136.8, 133.9, 130.8, 128.9, 127.5, 124.4, 119.6, 119.5, 115.4, 82.2, 77.4, 73.6, 62.5, 53.3, 37.1, 35.2,
29.3, 27.8, 24.1, 24.0, 19.4.  ESI-MS: [M+H]+ 602.1304 (obsd), 602.2267 (calcd).
Nα-4-pentenoyl-phospho(1-nitrophenylethyl)-L-Tyrosine tert-butyl ester: Nα-4-pentenoyl-phospho(1-
nitrophenylethyl-2-cyanoethyl)-L-Tyrosine tert-butyl ester (400 mg, 0.66 mmol) was dissolved in methanol (MeOH,
15 mL) and potassium hydroxide (KOH, 1.3 mL of stock solution 34 mg/mL in water, 0.79 mmol) was added.  After
10 minutes, TLC (Rf = 0.30, 1:10:90 Et3N/MeOH/CH2Cl2) shows that the starting material has been consumed. The
reaction mixture was poured into water (150 mL) with brine (50 mL) and acidified with HCl to pH ~ 1.  The product
was extracted with EtOAc (2 x 50 mL). The combined organic layers were dried over Na2SO4, decanted, and
concentrated under reduced pressure to give the desired product as a white solid in quantitative yield. No further
purification was necessary. 1H-NMR (400 MHz, CDCl3, δ): 1.38 (s, 9H), 1.63 (dd, 3H, JHH = 2.7 Hz, JHH = 3.5 Hz),
2.24-2.32 (m, 4H), 2.95-3.03 (m, 2H), 4.68 (br s, 1H), 4.96 (dd, JHH = 1.4 Hz, J2 = 10.2 Hz), ), 4.99 (dd, JHH = 1.5
Hz, JHH = 17.1 Hz), 5.70-5.78 (m, 1H), 6.08 (q, 1H, JHH = 6.3 Hz), 6.27 (br s, 1H), 6.94-7.01 (m, 4H), 7.40 (t, 1H,
JHH = 8.1 Hz), 7.59 (t, 1H, JHH = 7.5 Hz), 7.74 (dd, 1H, JHH = 1.0 Hz, JHH = 7.9 Hz), 7.93 (td, 1H, JHH = 1.5 Hz, JHH =
8.2 Hz), 10.85 (br s, 1H). 13C-NMR (100.6 MHz, CDCl3, δ): 172.5, 170.7, 149.6, 146.6, 137.9, 136.9, 134.1, 133.1,
130.8, 128.7, 128.0, 124.5, 120.0, 115.9, 82.8, 73.1, 53.7, 37.5, 35.5, 29.5, 28.1, 24.5.  ESI-MS: [M+H]+ 549.1981
(obsd), 549.1996 (calcd).
Nα-4-pentenoyl-phospho(1-nitrophenylethyl)-L-Tyrosine cyanomethyl ester (6): Nα-4-pentenoyl-phospho(1-
nitrophenylethyl)-L-Tyrosine tert-butyl ester (400 mg, 0.81 mmol) was dissolved in anhydrous CH2Cl2 (10 mL) and
the resulting solution was cooled to 0 °C.  TFA (10 mL) was slowly added to the reaction mixture, and the solution
was stirred in the dark at 0 °C for 30 minutes, and then at room temperature for another 30 minutes. The reaction
mixture was concentrated under reduced pressure, then re-dissolved in CH2Cl2 and concentrated three times to
remove the TFA. The resulting residue was dissolved in chloroacetonitrile (1 mL, 15.8 mmol), and DBU (607 µL,
4.06 mmol) was added dropwise over the mixture; the reaction was allowed to stir in the dark overnight. The
reaction mixture was then diluted with EtOAc (50 mL) and washed with a mixture of water (50 mL), brine (150 mL)
and 6M HCl (2 mL).  The combined organic layers were dried over Na2SO4, decanted, and concentrated under
reduced pressure to give a dark brown oil that was purified by reversed phase HPLC to give the desired product as a
sticky solid in 47.0 % yield (201 mg, 95:5 to 5:95 water/acetonitrile/0.1%TFA over 30 minutes, Rt = 22.50 min).
1H-NMR (400 MHz, CDCl3, δ): 1.65 (dd, 3H, JHH = 5.2 Hz, JHH = 0.86 Hz), 2.29 (s, 4H), 2.96, 3.12 (m, 2H), 4.97 (d,
2H, JHH = 1.1 Hz), 4.98 (dd, 2H, JHH = 26 Hz, JHH = 1.0 Hz), 5.64-5.79 (m, 1H), 6.06 (q, 1H, JHH = 6.6), 6.72 (br s,
1H), 6.96-6.99 (m, 4H), 7.42 (td, 1H, JHH = 7.7 Hz, JHH = 1.3 Hz), 7.61 (td, 1H, 7.6 Hz, JHH = 0.95 Hz), 7.76  (dd,
1H, JHH = 7.8, JHH = 0.97), 7.92 (d, 1H, JHH = 8.2 Hz), 10.4 (br s, 1H). 13C-NMR (100.6 MHz, CDCl3, δ): 174.1,
170.1, 150.0, 146.7, 137.8, 136.4, 134.2, 132.1, 130.6, 128.9, 128.1, 124.5, 120.5, 116.2, 114.1, 73.0, 53.4, 49.2,
36.7, 35.1, 29.4, 24.5. ESI-MS: [M+H]+ 532.1477 (obsd), 532.1485 (calcd).
Coupling to pdCpA (11):  pdCpA (10) was synthesized as previously reported.3 In general, the coupling reactions
were performed on a 20 to 50 µmole scale; additionally, the pdCpA (1.2 equivalents), Nα-4-pentenoyl-phospho(1-
nitrophenylethyl)-L-Serine, -Threonine, or -Tyrosine cyanomethyl ester (1.0 equivalents), and tetrabutylammonium
acetate (NBu4OAc) were dried under vacuum before use.  A 250 mM solution of NBu4OAc was made in anhydrous
N,N-dimethylformamide (DMF).  The pdCpA was dissolved to 130 mM concentration with the NBu4OAc solution,
and kept under inert atmosphere.  This mixture was then added to the amino acid ester, and kept dark under inert
atmosphere.  The reaction was monitored by analytical reversed phase HPLC.  When the amino acid ester was
consumed, the reaction was quenched with 2:1 water/MeCN with 0.1 % TFA (1.5 to 2.0 mL, or ~12 mM final
concentration of product).  The product was purified by reversed phase HPLC (93:7 to 0:100 water/MeCN/0.1 %
TFA over 35 minutes) and confirmed by ESI-TOF MS.  pdCpA-4PO-cpSer, Rt = 23.23 min, [MNa]+ 1059.0,
[MNaH]2+ 530.0 (obsd), 1057.7, 529.3 (calcd); pdCpA-4PO-cpThr, Rt = 23.40 min, [MNa]+ 1072.9, [MH]+ 1049.0
(obsd), 1072.7, 1049.7 (calcd). pdCpA-4PO-cpTyr, Rt = 25.80 min, [MH]+ 1111.2, [M+2H]2+ 556.1 (obsd), 1111.0,
556.0 (calcd).
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Ligation to tRNACUA-CA:  tRNACUA-CA was transcribed from linearized DNA as previously reported4 and stored in
diethyl pyrocarbonate (DEPC) treated water at – 80 °C.  Ligations were performed as published1, 4, 5 with two
changes: the ligation procedure was increased 1.5-fold, and the following desalting step was added.  After
redissolution in 20 µL 1mM NaOAc, pH 4.5, aminoacyl-tRNACUA samples were desalted using BD Biosciences
CHROMA SPIN-30 DEPC H2O columns (following manufacturer’s instructions).  The desalted samples were
quantified using UV A260, confirmed by MALDI-TOF MS on 3-hyroxypicolinic acid (3-HPA) matrix1, and stored at
– 80 °C.
tRNACUACpSer: [MH]+ 24, 732 (obsd), 24, 734 (calcd).
tRNACUACpThr: [MH]+ 24, 755 (obsd), 24, 748 (calcd).
tRNACUACpTyr: [MH]+ 24, 807 (obsd), 24, 810 (calcd).
Calculated masses based on external BSA calibration, and internal referencing to 74 base tRNACUA-CA (23, 716) and
76 base tRNACUA (24, 334).  Other tRNAs produced as previously described.5
Figure S1  MALDI-TOF MS of tRNACUA.
VASP-WT and –S153TAG constructs:  The VASP gene was received from the Gertler Lab (Massachusetts
Institute of Technology) in a pBS-KSII vector with an upstream T5 promoter.  The site-specific mutagenesis was
performed following the Stratagene QuikChange protocol and the following primers: sense 5’-GAG CGC CGG
GTC TAG AAT GCA GGA GGC CC; antisense 5’-GGG CCT CCT GCA TTC TAG ACC CGG CGC TC.  Several
colonies were selected, DNA was purified by standard procedure, and submitted for sequencing; one sample with
the correct sequence was kept for further use.
Both the WT and S153TAG VASP genes were amplified from the pBS-KSII vectors using PCR with Pfu
Turbo Polymerase and the following primers: forward 5’-C ACC ATG ACG GAG ACG GTC; reverse 5’-AGG
AGA ACC CCG CTT CCT CAG.  The products were purified by agarose gel electrophoresis and stored at -20 °C.
The PCR products were then used in the TOPO directional cloning reaction as described by the manufacturer
(Invitrogen, TOPO Directional Cloning: pcDNA3.1/V5-His).  Several colonies were selected and plasmid DNA
purified by standard procedure.  The DNA was screened by a single restriction enzyme digest: Sal I will cut the
empty vector into two pieces, 2.3 and 3.2 kb in length, while it will cut the pcDNA/VASP vectors into two pieces,
2.1 and 4.4 kb in length.  Several samples with the insert were submitted for sequencing, and one of each plasmid
sample with the correct sequence was stored at –20 °C for future use.
mRNA run-off transcription:  Plasmid DNA of WT and S153TAG VASP was amplified in DH5α cells using
standard protocol.  Approximately 100 µg of each plasmid were linearized with PmeI (cuts immediately downstream
of the C-terminal His-tag).  Linearized DNA was purified by agarose gel electrophoresis followed by PCI extraction,
ethanol preceipitation, and re-dissolving in DEPC water.  Run-off transcription of the genes was performed using
the T7 mMessage mMachine Kit (Ambion) and following manufacturer protocol.  The mRNA was purified by PCI
extraction and stored at –80 °C.  Analysis by gloxal/agaorse gel confirmed the correct size of the transcripts.
nAChR transcripts were run off as previously described.6
Aminoacyl-tRNACUA Deprotection:  6-nitroveratryloxycarbonyl- (NVOC) protected aminoacyl-tRNACUAs (1
µg/µL) were deprotected by 5 minutes of irradiation with a 1000 W Hg/Xe arc lamp (Oriel, Stratford, CT) operating
9at 400 W equipped with WG-335 and UG-11 filters (Schott, Elmsford, NY).  4-pentenoyl- (4PO) protected
aminoacyl-tRNACUAs were deprotected by a 10 minute incubation with 1 equivalent fresh saturated I2 in H2O.  4PO-
protected aminoacyl-tRNACUAs are stored at 2 µg/µL; the final concentration is 1 µg/µL after I2 treatment.
In Vitro Translation:  In vitro protein synthesis was carried out using the Promega (Madison, WI) rabbit
reticulocyte lysate translation kit according to the manufacturer’s instructions. For nAChR translations, the
following reagents were combined and incubated for 1 hour at 30 °C: 1.5 µL DEPC H2O, 0.75 µL complete amino
acids (1mM), 0.5 µL Roche (Basel, Switzerland) RNAse inhibitor, 4 µL deprotected aminoacyl-tRNACUA
(suppression: 1 µg/µL) or DEPC H2O (unsuppressed), 1 µL mRNA (VASP-WT: 1.0 µg/µL, VASP-S153TAG: 0.1
µg/µL), and 16.25 µL lysate.  For VASP translations, the following reagents were combined and incubated for 3
hours at 30 °C: 10 µL DEPC H2O, 6 µL complete amino acids (1mM), 4 µL Roche (Basel, Switzerland) RNAse
inhibitor, 32 µL deprotected aminoacyl-tRNACUA (suppression: 1 µg/µL) or DEPC H2O (unsuppressed), 8 µL
mRNA (VASP-WT: 1.0 µg/µL, VASP-S153TAG: 0.1 µg/µL), and 140 µL lysate.
Ni-NTA Purification of His-Tagged Proteins:  The following buffers were used in the purification and
concentration of His-tagged VASP proteins:
• Buffer A: 100 mM NaH2PO4, 2% SDS, 2 mM β-mercaptoethanol, pH 8.0
• Buffer B: 50 mM NaH2PO4, 150 mM NaCl, 2 mM β-mercaptoethanol, pH 8.0
• Buffer C: 50 mM NaH2PO4, 150 mM NaCl, 2 mM β-mercaptoethanol, pH 7.0
• Buffer D: 50 mM NaH2PO4, 150 mM NaCl, 2 mM β-mercaptoethanol, pH 4.5
• Buffer E: 50 mM NaH2PO4, 150 mM NaCl, 2 mM β-mercaptoethanol, 1X BSA, pH 7.0.
400 µL Qiagen Ni-NTA Superflow (Valencia, CA) were washed three times with 400 µL Buffer B.  200 µL
translation mix was combined with 400 µL Buffer A, added to the beads, and rocked at room temperature for two
hours.  The beads were washed four times with 400 µL Buffer C.  400 µL Buffer D was added to beads, which were
rocked for two hours at room temperature.  Buffer D was removed from the beads, another 400 µL Buffer D was
added, and the beads were rocked at room temperature for two hours.  Buffer D elutions were combined.
Three Millipore (Billerica, MA) Ultrafree MC Biomax (30 kDa NMWL) centricon columns were used per
translation for concentrating solutions, one for loading Buffer A, one for Buffer C washes, and one for Buffer D
elutions.  Columns were blocked for 2 hours at room temperature with Buffer E, which was removed by pipetting.  2
X 400 µL Buffer B were added to each column and removed by pipetting (removes excess BSA).  Loading Buffer
A, Buffer C washes, and Buffer D elutions were added to the columns and concentrated by centrifuging the columns
at 4000 x g until their respective volumes were reduced to 40 µL.  Buffer B was used to dilute the concentrated
Buffer A, Buffer C, and Buffer D solutions to 100 µL (final pH ~6.6).  Samples stored at –80 °C.  Concentrated
Buffer D solutions are hereafter referred to as VASP-WT (unsuppressed) or Suppressed VASP.
λ−PPase Treatment: λ-PPase dephosphorylation of murine VASP Ser153 is well-precedented.7
Dephosphorylation was performed with New England Biolabs (Beverley, MA) Lambda Protein Phosphatase (λ-
PPase), according to the manufacturer’s instructions. VASP samples (WT: 2 µL, Suppressed: 10 µL) were dissolved
in sterile H2O to a total volume of 15.5 µL.  2 µL 20 mM MnCl2, 2 µL λ-PPase Buffer, and 0.5 µL λ-PPase enzyme
were added to a total volume of 20 µL.  This mixture was incubated 0.5 hours at 30°C and stored at -80°C.
PKA treatment: PKA phosphorylation of murine VASP Ser153 is well-precedented.7 Phosphorylation was
performed with New England Biolabs cAMP-dependent Protein Kinase (PKA), according to the manufacturer’s
instructions. VASP samples (WT: 2 µL, Suppressed: 10 µL) were dissolved in sterile H2O to a total volume of 15.5
µL.  2 µL 10 mM ATP, 2 µL PKA Buffer, and 0.5 µL PKA enzyme were added to a total volume of 20 µL.  This
mixture was incubated 0.5 hours at 30°C and stored at -80°C.
Caging Group Photolysis:  Irradiation of the His-Tag purified VASP samples was performed with the arc lamp
assembly described above (Aminoacyl-tRNACUA Deprotection).  WT samples were treated with λ -PPase as
described above; after dephosphorylation the 20 µL sample was irradiated for 5 minutes at room temperature.  CSer
and CpSer samples were diluted with sterile H2O to a total volume of 15.5 µL, irradiated for 5 minutes at room
temperature, and then treated with PKA or λ-PPase (respectively) as described above.
nAChR PAGE Analysis:  PAGE samples were prepared by mixing 10 µL of unpurified rabbit reticulocyte
translation mix with 4 µL 6X SDS gel loading buffer8 and diluting to a total volume of 24 µL. Samples were run at
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150 V on a 10% polyacrylamide Readygel (BioRad, Hercules, CA) in 1X Tris/Glycine/SDS buffer (10X stock from
BioRad).  Protein was transferred to nitrocellulose membrane, which was blocked with 5% milk in 1 X PBS (Irvine
Scientific, Santa Ana, CA) with 0.1 % (v/v) Tween 20 (Sigma-Aldrich) for 1 hour.  The blot was labeled with mouse
anti-HA epitope primary antibody (Covance Research Products, Grand Rapids, MI) for 1 hour at a 1:3000 dilution in
the 5% milk solution.  After washing 3 times 1 X PBS + 0.1 % (v/v) Tween 20, the membrane was labeled for 1
hour with horse radish peroxidase-conjugated goat anti-mouse secondary antibody (Jackson Immunoresearch
Laboratories, West Grove, PA).  The blot was washed 3 times 1 X PBS + 0.1 % (v/v) Tween 20 and developed with
Supersignal West Pico chemiluminescence reagents from Pierce (Rockford, IL) on Amersham (Buckinghamshire,
England) Hyperfilm.
Figure S2  Suppression efficiency in nAChR-A122TAG.  Lanes (Left to Right): 1, WT translation; 2-7, A122TAG
mRNA with tRNACUA charged with amino acids listed above lanes.  “No AA” refers to full length, but uncharged,
tRNA.  All lanes loaded with 10 µL.  C2pTyr synthesis is described elsewhere.9
VASP PAGE Analysis:  PAGE samples were prepared by mixing 4 µL 6X SDS gel loading buffer8 with one of the
following: 2 µL of unpurified rabbit reticulocyte translation mix; 10 µL concentrated loading Buffer A, wash Buffer
C, or elution Buffer D; 20 µL enzymatically-treated VASP.  The final samples were diluted to 24 µL.  Samples were
run at 150 V on a 12% polyacrylamide Readygel (BioRad) in Tris/Glycine/SDS.  Protein was transferred to
nitrocellulose membrane, which was blocked with 5% BSA (minimum 96%, Sigma-Aldrich, St. Louis, MO) in 1 X
PBS with 0.1 % (v/v) Tween 20 for 1 hour.  The blot was labeled with rabbit anti-VASP primary antibody (a gift
from the Gertler lab, Massachusetts Institute of Technology) for 1 hour at a 1:3000 dilution in the 5% BSA solution.
After washing 3 times 1 X PBS + 0.1 % (v/v) Tween 20, the membrane was labeled for 1 hour with horse radish
peroxidase-conjugated goat anti-rabbit secondary antibody (Upstate, Charlottesville, VA).  The blot was washed 3
times 1 X PBS + 0.1 % (v/v) Tween 20 and developed as above.
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Figure S3  Suppression efficiency in VASP-S153TAG.  Lanes (Left to Right): 1, Molecular Weight Markers; 2, WT
translation mix, unpurified (2 µL); 3, WT Buffer C Wash (10 µL); 4, WT Buffer D elution (2 µL); 5, S153TAG
mRNA and tRNACUA-CSer translation mix, unpurified (2 µL); 6, CSer Buffer C Wash (2 µL); 7, CSer Buffer D
elution (10 µL); 8, S153TAG mRNA and tRNACUA-CpSer translation mix, unpurified (2 µL); 9, CpSer Buffer C
Wash (2 µL); 10, CpSer Buffer D elution (10 µL).
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NMR Data
O-1-(2-nitrophenyl)ethyl-O’-tertbutyl-N,N-diethyl phosphoramidite (3)
13
Nα-4-pentenoyl-O-tert-butyl-L-Serine
14
Nα-4-pentenoyl-O-tert-butyl-L-Serine cyanomethyl ester
15
Nα-4-pentenoyl-L-Serine cyanomethyl ester (2a)
16
Nα-4-pentenoyl-phospho(1-nitrophenylethyl)-L-Serine cyanomethyl ester (5a)
17
18
Nα-4-pentenoyl-O-tert-butyl-L-Threonine
19
Nα-4-pentenoyl-O-tert-butyl-L-Threonine cyanomethyl ester
20
Nα-4-pentenoyl-L-Threonine cyanomethyl ester (2b)
21
Nα-4-pentenoyl-phospho(1-nitrophenylethyl)-L-Threonine cyanomethyl ester (5b)
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Nα-4-pentenoyl-L-Tyrosine tert-butyl ester
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Nα-4-pentenoyl-phospho(1-nitrophenylethyl-2-cyanoethyl)-L-Tyrosine tert-butyl ester
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Nα-4-pentenoyl-phospho(1-nitrophenylethyl)-L-Tyrosine tert-butyl ester
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Nα-4-pentenoyl-phospho(1-nitrophenylethyl)-L-Tyrosine cyanomethyl ester (6)
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